儿童隐源性缺血性卒中队列中卵圆孔未闭的患病率
本研究比较了25例隐源性动脉缺血性卒中(AIS)患儿、54例已知病因AIS患儿和209例健康对照的卵圆孔未闭(PFO)患病率、特征及卒中复发风险。结果显示隐源性卒中组PFO患病率(28%)高于已知病因组(5.6%,p=0.009)和健康对照组(11.5%,p=0.03),但PFO与2年卒中复发风险无关(HR 2.0,95%CI 0.4-9.3,p=0.39)。
要点
- 隐源性卒中患儿PFO患病率高于已知病因卒中和健康儿童。
- PFO未增加儿童卒中2年复发风险。
- 隐源性卒中合并PFO的最佳二级预防尚不明确。
核心结论
- 隐源性缺血性卒中患儿PFO患病率高于已知病因卒中患儿和健康对照,但PFO未与卒中复发风险增加相关。
研究设计与样本
- 病例对照分析,来自14年前瞻性单中心儿童AIS队列,比较25例隐源性AIS、54例已知病因AIS和209例健康对照的经胸超声心动图(TTE)。
主要发现
- 隐源性组PFO患病率为28%(7/25),已知病因组为5.6%(3/54),对照组为11.5%(24/209)。
- 隐源性组与已知病因组比较p=0.009,与对照组比较p=0.03。
- 右向左分流和房间隔瘤 presence 无显著差异。
- 整个卒中队列中位随访20.9个月,2年无卒中复发在PFO组与非PFO组无差异(HR 2.0,95%CI 0.4-9.3,p=0.39)。
关键数值与推荐
- 隐源性AIS患儿PFO患病率28%,已知病因AIS患儿5.6%,健康对照11.5%。
- PFO与2年卒中复发风险无显著关联(HR 2.0,95%CI 0.4-9.3,p=0.39)。
临床怎么用
- 儿童隐源性卒中应评估PFO,但PFO存在不改变复发风险,二级预防决策需个体化。
局限性
- 单中心、样本量较小,隐源性卒中组仅25例。
- PFO与复发风险的分析可能受样本量限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: To determine the significance of patent foramen ovale (PFO) in childhood stroke, we compared PFO prevalence, PFO features, and stroke recurrence risk in 25 children with cryptogenic arterial ischemic stroke (AIS), 54 children with AIS from a known etiology, and 209 healthy controls. METHODS: We performed a case-control analysis of a 14-year prospectively enrolled single-center cohort of children with AIS who underwent transthoracic echocardiogram (TTE) and compared them to TTEs of otherwise healthy children evaluated for benign cardiac concerns. Stroke patients 29 days to 18 years of age at stroke ictus with confirmed acute AIS on imaging, availability of complete diagnostic studies of stroke risk factors, including TTE images available for central review, and at least 1 follow-up evaluation after index stroke were included. Presence of PFO and high-risk PFO features were assessed by 2 independent, blinded reviewers and compared between groups with the Fisher exact test. Stroke/TIA recurrence risk was determined from Cox proportional hazards models. RESULTS: Of 154 children with first-ever AIS, 79 were eligible; 25 had cryptogenic AIS, and 54 had a known cause. PFO prevalence was higher in the cryptogenic group (7, 28%) compared to both the known stroke etiology group (3, 5.6%, p = 0.009) and controls without stroke (24, 11.5%, p = 0.03). There were no significant differences in presence of right-to-left shunt and atrial septal aneurysm. Median follow-up time for entire stroke cohort was 20.9 months. Stroke-free recurrence at 2-years did not differ between children with and without PFO (HR 2.0, 95% CI 0.4-9.3, p = 0.39). DISCUSSION: PFO prevalence was higher in children with cryptogenic stroke compared to patients with AIS with known etiology and healthy controls. PFO was not associated with increased recurrence risk. Optimal secondary preventive treatment in children with cryptogenic stroke and PFO remains uncertain and requires further study. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that children with cryptogenic ischemic stroke have an increased frequency of PFO compared to children with ischemic stroke of known etiology and healthy controls.
引用
- Shih EK, Beslow LA, Natarajan SS, et al. Prevalence of Patent Foramen Ovale in a Cohort of Children With Cryptogenic Ischemic Stroke. Neurology. 2021. PMID: 34649876. doi:10.1212/WNL.0000000000012892
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。